iSpecimen agrees to buy AI assets from Foldlab for $4.5 million
The deal covers two AI products and requires iSpecimen shareholder approval before it can close.
SEC filing
Latest
4 stories
Friday, September 4
Monday, August 31
iSpecimen names Shahin Behroyan as CEO, replacing Katharyn Field
iSpecimen's board appointed Behroyan effective August 26, 2026, under an independent contractor agreement paying $350,000 annually.
SEC filing
Friday, August 14
iSpecimen settles WestPark dispute, signs $2M IR consulting deal
Two 8-K filings show iSpecimen resolved an underwriter arbitration for $97,500 and separately agreed to pay an investor relations firm $2 million for a three-month campaign.
SEC filing (2)
Friday, August 7
iSpecimen closes $5 million public offering of stock and pre-funded warrants
The Woburn, Mass. biospecimen marketplace company closed the offering on August 7, 2026, after pricing it at $1.30 per share.
SEC filing (2)